Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03188042 · ClinicalTrials.gov registry record · NA

A Study Using Transorbital Alternating Current Stimulation for People With Glaucoma

A NA study of Glaucoma, sponsored by NYU Langone Health.

Completed
Registry status
NA
Development phase
18
Enrollment target
1
Study location

NCT03188042 is a NA study of Glaucoma that has completed, run by NYU Langone Health. The registered enrollment target is 18 participants, below the 910-participant average among 92 other Glaucoma trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03188042, a NA study of Glaucoma, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
NA
Development phase
18 participants
Enrollment target
1
Study location

Study Summary

This pilot study will test the preliminary efficacy and feasibility of an intervention protocol for one method of electric current stimulation, repetitive transorbital alternating current stimulation (rtACS), to treat visual impairment in people with glaucoma. We will evaluate a study protocol to use in future clinical trials to test the effectiveness of rtACS to ameliorate the progressive effects of vision loss both structurally and functionally in the eye, the visual pathway, and in regard to people's independence (i.e., functional ability). In this prospective, randomized controlled, double-masked pilot study, we will: 1) determine an effect of rtACS on ophthalmic structure and function (from retina to visual brain), 2) assess the methodology of procedures for assessment of people's functional ability and quality of life (QoL) to determine an effect of rtACS, and 3) assess the feasibility and implementation of the pilot study protocol for a larger multi-site, randomized controlled trial.

Conditions Studied

Glaucoma

Interventions

  • DEVICE Sham Intervention
  • DEVICE rtACS Stimulation

Study Locations (1)

New York

  • New York University School of Medicine - New York

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2017-12-14
Est. Completion 2022-10-20
Phase NA

Sponsor

NYU Langone Health

1,164 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03188042

The ClinicalTrials.gov registry entry for NCT03188042 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 910-participant average among 92 other Glaucoma trials with a reported enrollment target (98% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Glaucoma appearing as the primary indexed condition, and to 2 interventions - of which Sham Intervention is the first listed.

NCT03188042 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT03188042 about?

NCT03188042 is a clinical study titled "A Study Using Transorbital Alternating Current Stimulation for People With Glaucoma". This pilot study will test the preliminary efficacy and feasibility of an intervention protocol for one method of electric current stimulation, repetitive transorbital alternating current stimulation (rtACS), to treat visual impairment in people with glaucoma. We will evaluate a study protocol to us...

What is the current status of trial NCT03188042?

This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2017-12-14. Estimated completion is 2022-10-20.

What conditions does trial NCT03188042 study?

This clinical trial studies the following conditions: Glaucoma.

What interventions are being tested in trial NCT03188042?

The interventions under investigation include: Sham Intervention (DEVICE), rtACS Stimulation (DEVICE).

Who is sponsoring clinical trial NCT03188042?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03188042 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Glaucoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Glaucoma

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.